Hyderabad: ETPharma will be hosting the second edition of the Next-Gen Lab-Con on July 26, 2024, at Le Meridien, Hyderabad. The conference aims to bring together industrial leaders to focus on the pharmaceutical landscape, which is rapidly evolving and to discuss what will be the future generation of pharma labs and their regulatory obligations
The second edition of ETPharma’s Next-Gen LabCon, themed ‘Future-Ready Labs: Analog to Digital’ will focus on the seamless progression of a product life cycle, heightened competition and building next-gen, future-ready pharma labs, which is crucial to fulfilling the demand for innovative therapies, enhancing approval rates, minimising expenses, accelerating time-to-market, and adhering to regulatory obligations.
The conclave will commence with a welcome address by Vikas Dandekar, Editor, ETPharma, followed by the Chief Guest’s address on the topic ‘Navigating the future of Pharmaceutical Exports: Quality Imperatives and Global Compliance’ by Raja Bhanu, Director General, Pharmexcil.
The Chief Guest’s address will be followed by a panel discussion on ‘Indian Laboratories – what does it take, to take it to a global scale?’. The panellists for the session will be Annaswamy Vaidheesh, Executive Chairperson, Suven Pharma; Dr KVS Ram Rao, CEO & Joint Managing Director, Granules India, Akhil Ravi, Chief Executive Officer, Aurigene Pharmaceutical Services, and Dr Sauri Gudlavalleti, Chief Operating Officer, Sai Lifesciences. The session will be moderated by Vikas Dandekar, Editor, ETPharma.
The session on ‘Indian Laboratories – what does it take, to take it to a global scale? will be followed by a panel discussion on ‘Role of Sensors, AI, ML, RPA in Enhancing R&D Experimentation’. The panellists for the session will be Dr Mandar Ghatnekar, Global Head of IT & Digital Transformation, Biocon Biologics; Chitti Babu, Chief Information Officer (CIO), Aurobindo Pharma; Rithesh Phalaksha, Director – Leading Digital Innovation, Novartis; and Dr Sujay Rajhans, President, Head R&D, JB Pharma. The session will be moderated by Chakravarthi AVPS, Chairman, Federation of Pharma Entrepreneurs – Telangana & Andhra Pradesh, FOPE South. The panel discussion on ‘Role of Sensors, AI, ML, RPA in Enhancing R&D Experimentation’ will be followed by a case study on Gen AI by Tushar Zade, CDO & CIO, Aurigene Pharmaceuticals Services Ltd.
The Gen AI case study will be followed by a panel discussion on ‘Ask the Experts- Upscaling to Electronic Batch Records: Lessons from a Pharmaceutical Manufacturer’. The panellists for the discussion include Dr Pavan Bhat, Executive Director, Natco Pharma, Sandeep Raktate, President – India & Ireland Operations, Amneal Pharmaceuticals. The session will be moderated by Vikas Dandekar, Editor, ETPharma.
The ‘Ask the Experts- Upscaling to Electronic Batch Records: Lessons from a Pharmaceutical Manufacturer’ session will be followed by another panel discussion on ‘Implementing Green Chemistry Principles in CDMO Operations: A Sustainable Digital Transformation Journey’. The panellists for the dialogue include Dr Vijayavitthal T Mathad, Chief Operating Officer, CRAMSN Research Park, Dr Damodharan Muniyandi, Chief Quality Officer, Global Quality & Regulatory Affairs, Sai Life Sciences Ltd; Dr Rakeshwar Bandichhor, Vice President and Head of Chemistry, API Process R&D, Dr Reddy’s Laboratories. The moderator for the session will be Ivy Louis, Board Member, Parenteral Drug Association (PDA Inc.); Director-Vienni Training & Consulting LLP.
The conference will conclude with the closing remarks by Prabhat Prakash, Senior Digital Content Producer, ETPharma.
